Patrice Lee
Vice President Research & Development Ambrosia Biosciences
Patrice Lee, PhD, is a seasoned biopharmaceutical leader with over two decades of experience in drug discovery, development, and translational research. Currently serving as Vice President of Research and Development at Ambrosia Biosciences, she oversees strategic innovation in therapeutic development.
Previously, Patrice held executive roles at Pfizer as Vice President of Pharmacology & Toxicology, and Array BioPharma, where she advanced key programs from preclinical to clinical stages. Her expertise spans pharmacology, toxicology, clinical development, and pharmacokinetics, honed through prior leadership positions at Ribozyme Pharmaceuticals and Amgen.
Patrice earned her PhD in Physiology from Duke University and is recognized for her strategic program management and contributions to advancing novel therapies.
Seminars
- Considering lifelong metabolic health for maintenance therapies beyond GLP-1s for better long term patient outcomes
- Identifying driving factors of meal-triggered dosing and behavioural reinforcement strategies to improve long-term outcomes by fostering metabolic health
- Exploring body composition and biomarkers as a gateway to improving life-long cardiometabolic health
- Highlight formulation challenges behind bioavailability and titration
- Predict market shifts if oral efficacy rivals injectables
- Discussing transition pipelines to small molecules to understand benefits and disadvantages of changing to different therapies
- Ensuring future portfolios against peptide production bottlenecks to reduce costs and unnecessary pollutants
